Latest Courses

Great Debates: Exploring Muscarinic Agonists in Schizophrenia Treatment

Breaking the Monoamine Barrier - Beyond Serotonin: The Role of the Glutamatergic System in MDD (Module 2)

Breaking the Monoamine Barrier - Glutamatergic Antidepressants in Practice: When and How to Use Them (Module 3)

Breaking the Monoamine Barrier - The Limits of Monoamines: Why Conventional Antidepressants Fall Short (Module 1)

Breaking the Monoamine Barrier - Personalizing Treatment: Strategies for Incorporating Glutamatergic Therapy (Module 4)

Great Debates: Exploring Muscarinic Agonists in Schizophrenia Treatment

Breaking the Monoamine Barrier: Defying Limitations with Glutamatergic Treatments for MDD (Proceedings from Psych Congress)

Unlocking Hope: Novel Perspectives on PTSD Assessment and Treatment (Proceedings from Psych Congress)

Exploring the Utility of Precision Serotonin Receptor Modulation to Address Residual Symptoms and Side Effects in MDD (Proceedings from Psych Congress)

Recognizing and Managing Anhedonia Associated with MDD in the Primary Care Setting: Current Strategies and Emerging Options

Atypical Antipsychotics for Depressive Episodes: Clinical Considerations and Strategies in BD vs MDD (Proceedings from Psych Congress)

Faculty Q&A: Treatment-Resistant Depression or Monoamine-Resistant Depression? Reconsidering Paradigms in Difficult-to-Treat Depression